Lenvatinib generic name is Lenvatinib Mesylate Capsules, during the administration of side effects may occur and long-term, usually 7 to 15 days after stopping the drug can be reduced or disappear. Lenvatinib mesylate capsule is a tyrosine kinase receptor inhibitor, can effectively inhibit the activity of the body tyrosine kinase receptor, inhibit the tumor pathological angiogenesis, inhibit tumor growth. Clinically, it is mainly used for patients with hepatocellular carcinoma that cannot be treated by surgical resection and have not received systemic systemic treatment. It is not recommended to use the drug during pregnancy, lactation, age under 18 years and other people. Some side effects may occur during the use of the drug, such as high blood pressure, proteinuria, hand-foot reaction, diarrhea, skin rash, etc. Individual differences in side effects are different, and these side effects may persist during the use of the drug. If the side effects of the drug are not tolerated, they will usually be reduced or disappear in about 7 to 15 days after stopping the drug. The use of Lenvatinib Mesylate Capsules needs to strictly follow the doctor’s instructions, and should not be purchased and taken at random.